Seattle, WA, United States of America

Bryan Cunitz

This inventor holds 11 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: University of Washington, Sonomotion Inc., University of Michigan. Active years: 2015-2024.

USPTO Granted Patents = 11 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Seatte, WA (US) (2018)
  • Seattle, WA (US) (2015 - 2023)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Journey of Bryan Cunitz

Introduction: Bryan Cunitz is a pioneering inventor based in Seattle, Washington, known for his groundbreaking contributions to the field of technology and medical devices.

Latest Patents: Bryan Cunitz holds several patents in the areas of ultrasound technology and medical devices, with his most recent patent focusing on a novel method for non-invasive treatment of kidney stones using focused ultrasound.

Career Highlights: Throughout his illustrious career, Bryan Cunitz has been at the forefront of innovation, working tirelessly to develop cutting-edge solutions that have the potential to revolutionize the healthcare industry. His work has been instrumental in advancing the field of ultrasound technology and improving patient outcomes.

Collaborations: Bryan Cunitz has collaborated with leading researchers, medical professionals, and technology experts to bring his inventions to life. His collaborative approach has led to the successful development and commercialization of several groundbreaking technologies.

Conclusion: Bryan Cunitz's dedication to innovation and his passion for pushing the boundaries of what is possible have established him as a prominent figure in the world of inventors. His work continues to inspire and pave the way for future advancements in the field of medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…